Author:
Haberer Jessica E.,Kidoguchi Lara,Heffron Renee,Mugo Nelly,Bukusi Elizabeth,Katabira Elly,Asiimwe Stephen,Thomas Katherine K.,Celum Connie,Baeten Jared M.
Funder
National Institute of Mental Health of the US National Institutes of Health
Bill and Melinda Gates Foundation
US Agency for International Development
Subject
Infectious Diseases,Public Health, Environmental and Occupational Health
Reference40 articles.
1. Current concepts for PrEP adherence in the PrEP revolution: from clinical trials to routine practice;Haberer;Curr Opin HIV AIDS,2016
2. HIV protective efficacy and correlates of tenofovir blood concentrations in a clinical trial of PrEP for HIV prevention;Donnell;JAIDS,2014
3. Anderson P Lama J Buchbinder S Guanira J Montoya O Casapia M Expanded case-control analysis of drug detection in the global iPrEx trial Presented at: 6th IAS Conf HIV Pathogenesis, Treatment, Prevention; 2011 July 17-20; Rome Italy
4. Emtricitabine-tenofovir concentrations and pre-exposure prophylaxis efficacy in men who have sex with men;Anderson;Sci Transl Med.,2012
5. A translational pharmacology approach to predicting outcomes of preexposure prophylaxis against HIV in men and women using tenofovir disoproxil fumarate with or without emtricitabine;Cottrell;J Infect Dis,2016
Cited by
66 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献